Autopsy report · NCT04467814
Better Together: Reablement and Caregivers
Cause of deathStaffing, sites or logistics
“Due to COVID-related issues had to change study design.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Na
- Sponsor
- University of British Columbia
- Sponsor type
- University, hospital or other
- Conditions
- Older Adults; Sedentary Behavior; Physical Activity; Caregiver
- Interventions
- Better Together; Usual Care
- Participants
- 0
- Sites
- 1
- Countries
- Canada
Trials that died the same way
- Diabetes Prevention With Lifestyle Intervention and Metformin Escalation
“COVID-19 led to changes in study design and an early end to data collection.” - A Trial Measuring ART-123 Ability to Prevent Sensory Neuropathy in Unresectable mCRC Subjects w/Oxaliplatin-based Chemo
“Study design was changed” - A Comparison of the Post-C/S Analgesic Effects of Neuraxial Duramorph vs Bilateral TAP Block With Liposomal Bupivacaine
“Standard of Care changed due to COVID-19 and thus had to stop the study.” - Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of Withdrawal
“COVID pandemic and enrollment issues necessitating an adjustment to the study design.” - A Study in Patients With Advanced Parkinson's Disease to Assess the Relative Bioavailability of Levodopa Administered as ND0612 Subcutaneous Infusion Versus Levodopa Administered as Carbidopa-Levodopa Enteral Suspension
“Decision to change the study design”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.